MEDIUM confidence: 100% data completeness, but the composite (57) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1.4B— | $1.9B+34.8% | $2.6B+40.7% | $2.8B+7.7% | $2.9B+2.5% |
| EPS (dil.) | $6.74— | $8.79+30.4% | $9.08+3.3% | $8.87-2.3% | $9.92+11.8% |
| Free Cash Flow | $582M— | $620M+6.5% | $320M-48.4% | $862M+169.1% | $127M-85.2% |
| Gross Margin | 98.3% | 90.0%-8.2pp | 73.4%-16.7pp | 70.1%-3.2pp | 75.0%+4.9pp |
| Operating Margin | 35.1% | 35.6%+0.5pp | 26.9%-8.6pp | 24.4%-2.5pp | 26.4%+2.0pp |
| Net Margin | 31.8% | 30.8%-1.0pp | 22.6%-8.2pp | 20.4%-2.2pp | 22.2%+1.8pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $162 avg across 5 analysts.
Buy-rated share 38% → 33% over ~3 months (-4pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $2.55 | $2.70 | +5.9% |
| Apr 2026 | $2.48 | $2.65 | +6.9% |
| Jan 2026 | $2.47 | $2.57 | +4.0% |
| Oct 2025 | $2.38 | $2.67 | +12.2% |
| Jul 2025 | $2.28 | $2.39 | +4.8% |
| May 2025 | $2.16 | $2.30 | +6.5% |
| Jan 2025 | $2.17 | $2.36 | +8.8% |
| Oct 2024 | $2.17 | $2.24 | +3.2% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$124K over 180 days (0 open-market buys, 1 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 5.7%/yr (revenue basis).
Base free cash flow $436M (avg FY2023–FY2025; latest year $127M) · equity value $10.5B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 57 for CFR indicates a moderately attractive stock, driven by its strong momentum, with a 12-month return of 35.2% and a bullish 50-day versus 200-day moving average. The stock's profitability also scores relatively high, with an ROE of 15.0% and an operating margin of 30.8%. However, its growth score is somewhat lower, due in part to an -85.2% decline in free cash flow growth, and its value score is middling, with a P/E of 16.0 and P/B of 2.3, indicating the stock trades at a moderate premium.